ARTICLE | Clinical News
Enbrel etanercept regulatory update
July 14, 2008 7:00 AM UTC
The EC approved an MAA from Wyeth for once-weekly Enbrel etanercept 50 mg to treat moderate to severe plaque psoriasis. The company already markets a 25 mg formulation of the recombinant p75 TNF rece...